Professor David Luesley MA MD FRCOG

 

School of Cancer Sciences

luesley-david-Cropped-110x146

Contact details

Telephone +44 (0)121 507 5337

Fax +44 (0)121 449 7438

Email davidluesley@nhs.net

Pan-Birmingham Gynaecological Cancer Centre
City Hospital
Dudley Road
Birmingham
B18 7QH

About

Professor Luesley is currently the Professor of Gynaecological Oncology at the University of Birmingham, UK, having graduated from Cambridge University and then Birmingham University Medical School in 1975. David became a fellow of the Royal College of Obstetricians and Gynaecologists in 1990 and was awarded the Victor Bonney prize by his college in 2002 and the Founders medal by the BSCCP in 2008.

Qualifications

  • MBChB 1975
  • MA (CANTAB) 1975
  • FRCOG1993
  • MD (B'HAM) 1985

Biography

Professor Luesley is currently the Professor of Gynaecological Oncology at the University of Birmingham, UK, having graduated from Cambridge University and then Birmingham University Medical School in 1975. David became a fellow of the Royal College of Obstetricians and Gynaecologists in 1990 and was awarded the Victor Bonney prize by his college in 2002 and the Founders medal by the BSCCP in 2008.

Since completing his clinical research fellowship in Gynaecological Oncology at the University of Birmingham (1980) he has remained research and clinically active in this field as well as directing Undergraduate Education in Obstetrics & Gynaecology. David has undertaken many roles at a regional, national and international level and have most recently focussed on improving educational standards in his subspecialty. He co-founded the subspecialty programme in Birmingham 20 years ago and has provided both clinical and research training to in excess of 30 UK and overseas postgraduates. He is a past president of the BSCCP and BGCS and during his term as president of the BSCCP introduced accreditation and a structured curriculum.

David was the first director of the Pan-Birmingham Gynaecological Cancer Centre when launched in 2005 and over the last 5 years the centre has become one of the largest in the UK and has gained an international reputation for high clinical standards and active participation in research.
His clinical and research interests include gynaecological oncology and vulvar disease.

Teaching

  • MBChB
    Year 2: Cancer causes to Cures
    Year 4 Oncology Module
    Year 5 Obstetrics and Gynaecology

Postgraduate supervision

Over 20 MD and PhD students over the last 20 years and continued supervision of subspecialty trainees in gyaecological oncology

Research

Clinical trials and translational research in pre-invasive and invasive gynaecological cancers with particular emphasis on vulval malignancy and pre-malignancy.

Other activities

Previous and Currrent National and International Appointments

  • President of the British Gynaecological Cancer Society
  • President of the British Society for Colposcopy and Cervical Pathology
  • Board member International Gynaecological Cancer Society
  • Board member European Society for Gynaecological Oncology
  • Senior International Editor IJGC
  • International Editor American Journal of Lower genital Tract Pathology
  • FIGO Expert Advisory Committee
  • MacMillan and Cancer Backup Clinical Advisory Board
  • RCOG Scientific Advisory/Subspecialty Committees
  • Editor NHSCSP Guidelines on the Screening programme

Publications

Original Papers
Total: 114 Total in last 5 yrs: 30

Other Papers
Total: 44 Total in last 5 yrs: 5

Chapters in Books
Total: 36 Total in last 5 yrs: 13

Books
Total: 19 Total in last 5 yrs: 12

Management of women who test positive for high risk types of human papillomaviruses: the HART study. (2003) Cuzick J., Szarewski A., Cubie H., Hulman G., Kitchener H., Luesley D et al. Lancet 362: 1871-76.

Lack of antibody responses to HPV-16 virus-like particles in women with CIN infected with a variant strain of HPV-16. (1997) Ellis J., Etherington IJ., Galloway D., Luesley DM and Young LS. Lancet (1997); 349: 1069-1070.

LLETZ-Evidence of its efficacy against HPV infection (2001) Mann CH., Steele JC., Burton A., Bailey AS., Etherington IJ and Luesley DM. Gynecol Oncol. 81:125-127.

Human papillomavirus (HPV) type 16-specific CD8+ T cell responses in women with high grade vulvar intraepithelial neoplasia Todd, R. W., Roberts, S., Mann, C. H., Luesley, D. M., Gallimore, P. H., & Steele, J. C. 2004a Int.J.Cancer, vol. 108, no. 6, pp. 857-862

Detection of CD8+ T cell responses to human papillomavirus type 16 antigens in women using imiquimod as a treatment for high-grade vulval intraepithelial neoplasia Todd, R. W., Steele, J. C., Etherington, I., & Luesley, D. M. 2004b, Gynecol.Oncol., vol. 92, no. 1, pp. 167-174.

Characterizing T-cell response in low-grade and high-grade vulval intraepithelial neoplasia, study of CD3, CD4 and CD8 expressions. (2004). Gul N., Ganesan R and Luesley DM. Gynecol.Oncol 94; 48-53

Women's experience of colposcopy: a qualitative investigation.Swancutt DR, Greenfield SM, Luesley DM, Wilson S.BMC Womens Health. 2011 Apr 13;11(1):11. [Epub ahead of print

Indication and outcome of repeat large loop excision biopsies of the cervix.Moss EL, Appleyard TL, Winning JM, Jones PW, Luesley DM. J Low Genit Tract Dis. 2011 Apr;15(2):89-92

Obstetrics and Gynaecology: an evidence-based text for the MRCOG. Second Edition Eds David M Luesley and Philip N Baker. Arnold. London 2010


Expertise

Gynaecological cancer; cytology; ovarian cancer; endometrial cancer; pre-invasive disease of the cervix; vaginal intraepithelial neoplasia; colposcopy; vulval disease

Alternative contact number available for this expert: contact the press office

Back to top